Return On Equity in % of NEXIEN BIOPHARMA, INC. from Q3 2015 to Q1 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NEXIEN BIOPHARMA, INC. quarterly/annual Return On Equity history and change rate from Q3 2015 to Q1 2025.
  • NEXIEN BIOPHARMA, INC. Return On Equity for the quarter ending 31 Mar 2025 was 0 %, a 44.5% decline year-over-year.
  • NEXIEN BIOPHARMA, INC. annual Return On Equity for 2024 was 0 %, a 56.8% decline from 2023.
  • NEXIEN BIOPHARMA, INC. annual Return On Equity for 2023 was 1 %, a 80.6% decline from 2022.
  • NEXIEN BIOPHARMA, INC. annual Return On Equity for 2022 was 8 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 0 -0 -44.5% 01 Jan 2025 31 Mar 2025
Q4 2024 0 -0 -43.9% 01 Oct 2024 31 Dec 2024
Q3 2024 0 -1 -59.8% 01 Jul 2024 30 Sep 2024
Q2 2024 0 -1 -56.8% 01 Apr 2024 30 Jun 2024
Q1 2024 0 -1 -59.5% 01 Jan 2024 31 Mar 2024
Q4 2023 1 -2 -71.1% 01 Oct 2023 31 Dec 2023
Q3 2023 1 -5 -76.4% 01 Jul 2023 30 Sep 2023
Q2 2023 1 -7 -80.6% 01 Apr 2023 30 Jun 2023
Q1 2023 2 -14 -87% 01 Jan 2023 31 Mar 2023
Q4 2022 3 -10 -73.4% 01 Oct 2022 31 Dec 2022
Q3 2022 5 -386 -98.5% 01 Jul 2022 30 Sep 2022
Q2 2022 8 +331 01 Apr 2022 30 Jun 2022
Q1 2022 15 +324 01 Jan 2022 31 Mar 2022
Q4 2021 13 +133 01 Oct 2021 31 Dec 2021
Q3 2021 391 +449 01 Jul 2021 30 Sep 2021
Q2 2021 -321 -295 -11.1% 01 Apr 2021 30 Jun 2021
Q1 2021 -308 -290 -16% 01 Jan 2021 31 Mar 2021
Q4 2020 -119 -111 -12.3% 01 Oct 2020 31 Dec 2020
Q3 2020 -57 -49 -5.9% 01 Jul 2020 30 Sep 2020
Q2 2020 -26 -21 -3.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -18 -14 -3.9% 01 Jan 2020 31 Mar 2020
Q4 2019 -8 -6 -1.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -8 -7 -4.6% 01 Jul 2019 30 Sep 2019
Q2 2019 -6 -5 -2.9% 01 Apr 2019 30 Jun 2019
Q1 2019 -3 -2 -1.1% 01 Jan 2019 31 Mar 2019
Q4 2018 -3 -0 -16.5% 01 Oct 2018 31 Dec 2018
Q3 2018 -1 +8 +85% 01 Jul 2018 30 Sep 2018
Q2 2018 -1 +2 +54.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -1 -3 -2.7% 01 Jan 2018 31 Mar 2018
Q4 2017 -2 -3 -10.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -9 -10 -32.6% 01 Jul 2017 30 Sep 2017
Q2 2017 -3 -4 -11.1% 27 Mar 2017 30 Jun 2017
Q1 2017 1 +1 +2% 01 Jan 2017 31 Mar 2017
Q4 2016 0 -0 -19.5% 01 Oct 2016 31 Dec 2016
Q3 2016 0 -1 -73% 01 Jul 2016 30 Sep 2016
Q2 2016 0 01 Apr 2016 30 Jun 2016
Q1 2016 0 01 Jan 2016 31 Mar 2016
Q4 2015 0 01 Oct 2015 31 Dec 2015
Q3 2015 1 01 Jul 2015 30 Sep 2015

NEXIEN BIOPHARMA, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 0 -1 -56.8% 01 Jul 2023 30 Jun 2024
2023 1 -7 -80.6% 01 Jul 2022 30 Jun 2023
2022 8 +331 01 Jul 2021 30 Jun 2022
2021 -321 -295 -11.1% 01 Jul 2020 30 Jun 2021
2020 -26 -21 -3.4% 01 Jul 2019 30 Jun 2020
2019 -6 -5 -2.9% 01 Jul 2018 30 Jun 2019
2018 -1 -1 -4.7% 01 Jul 2017 30 Jun 2018
2017 0 -1 -1.8% 01 Jul 2016 30 Jun 2017
2016 0 01 Jul 2015 30 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.